Follow Us on StockTwits

Houston Methodist Hospital Purchases Mazor X System

Posted by on May 18, 2017 9:07 PM
Tags: , , , ,
Categories: Stocks

May 18, 2017: Houston Methodist Hospital in Texas purchased the Mazor X system. Dr. Paul Holman, Neurosurgeon and Clinic Director of Spine Surgery at Houston Methodist Hospital, performed the first procedure earlier this month.

Houston Methodist consists of seven hospitals in the Greater Houston metropolitan area and is one of the nation’s leading health systems and academic medical centers with physician-scientists working on more than 800 clinical trials. In addition to advancing medicine and treatments, the health system’s dedication to exceptional patient care is clear after being named the No. 1 hospital in Texas for the fifth year in a row by U.S. News & World Report.

“Houston Methodist is a world-renowned health system providing top-level patient care and we are honored that they have chosen the Mazor X system for their spine surgery program,” said Mazor Robotics, Inc. CEO Christopher Prentice. “The Mazor X system was designed to better utilize clinical diagnostics and data in order to assist in the improvement of spine surgery, and with a leading academic institution such as Houston Methodist involved, we look forward to this possibility.”

May 15, 2017: Mazor Robotics has explosive revenue growth. Last Wednesday, May 10th, 2017, the company reported Q1 EPS of -$0.08 versus the -$0.20 estimate. Revenue also beat coming in at $11.7 million versus the $11.5 million estimate.

The CEO Ori Hadomi said, “Our revenue growth was driven by two factors. First, we supplied 12 Mazor X systems as we continued to process our 2016 year-end backlog. Second, we had record utilization by our installed base during the quarter. The enthusiasm for the Mazor X continues, and to date we have received four purchase orders for the Mazor X in the second quarter of 2017.”

This is a high risk play as this stock does not meet my usual EPS growth requirements that I screen for.

Mazor Robotics Stock Chart


The Finviz screener settings used to find Mazor Robotics are: Sales past 5 years 43.9%, Sales Q/Q 82.8%, Institutional Transactions 4.61%

Mazor Robotics makes robotic medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States, Western Europe, Eastern Europe, and Asia. The company was founded in 2001 by researchers at the Technion Robotics Laboratory at the Israel Institute of Technology. The company is still based in Israel but it also has U.S. headquarters in Orlando, Florida.

Jim Cramer with Mad Money interviewed Mazor Robotics CEO Ori Hadomi in April 2017:

StockTwits